{
    "2021-12-21": [
        [
            {
                "time": "",
                "original_text": "华大基因现2笔大宗交易 均为折价成交",
                "features": {
                    "keywords": [
                        "华大基因",
                        "大宗交易",
                        "折价成交"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因现2笔大宗交易 共成交1,435.59万元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因今日大宗交易成交17.55万股，成交价81.8元折价7.0%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "大宗交易",
                        "折价",
                        "成交量",
                        "成交价"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：公司利用测序平台和质谱平台可以实现多个方向的研究和服务",
                "features": {
                    "keywords": [
                        "华大基因",
                        "测序平台",
                        "质谱平台",
                        "研究服务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：在实现海外业务可持续发展方面具有显著优势",
                "features": {
                    "keywords": [
                        "华大基因",
                        "海外业务",
                        "可持续发展",
                        "优势"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：截至2021年10月28日深圳和玉高林持有3.57%公司股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "持股比例",
                        "深圳和玉高林"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：“火眼”实验室已在國內多个主要城市落地",
                "features": {
                    "keywords": [
                        "华大基因",
                        "火眼实验室",
                        "国内城市",
                        "落地"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：深圳和玉高林股权投资合伙企业（有限合伙）持有公司3.57%股权",
                "features": {
                    "keywords": [
                        "华大基因",
                        "深圳和玉高林",
                        "持股比例"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因副总裁刘娜受邀参与2021首届南方论健高峰论坛，探索一站式精准健康管理服务",
                "features": {
                    "keywords": [
                        "华大基因",
                        "刘娜",
                        "南方论健",
                        "精准健康管理"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "健康管理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}